DeSUMOylation of FoxA1 at K6 promotes FoxA1 degradation and then inhibits Sirt6 transcription, thereby suppressing fatty acid β-oxidation and facilitating NAFLD development. This evidence concerns the gene FOXA1 and metabolic dysfunction-associated steatotic liver disease.